Kalbe Genexine Biologics Enters Into an Exclusive Licensing of Immuno-Oncology Product with Henlius of China Jakarta, 16 September 2019 – PT Kalbe Genexine Biologics (KG Bio), a joint venture of Kalbe Farma Tbk (Kalbe), and Genexine, Inc. enters into an exclusive collaboration for HLX10 an...
Kalbe Launches New Panel in Genetic Examination Kalbe Launches New Panel in Genetic Examination Jakarta, August 23, 2019 - PT Kalbe Farma Tbk (Kalbe) today through one of its subsidiaries, PT Bifarma Adiluhung, that produces the genetic testing product, Nutrigen-me; launched four new panels:...
Maintain Better Company Performance Jakarta, July 31, 2019 – PT Kalbe Farma Tbk and Subsidiaries (“Kalbe” or “the Company”) today announced net sales of Rp 11,179 billion for the first semester of 2019,...